[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338496-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338496-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","fbp1-over-expression-suppresses-hif-1-in-papillary-thyroid-cancer","FBP1 over-expression suppresses HIF-1α in papillary thyroid cancer","","Papillary thyroid carcinoma is often slow-growing, yet a subset becomes aggressive with local invasion or distant metastasis. This study evaluates FBP1 expression in PTC tissues and tests its impact on proliferation, apoptosis, and invasion in PTC cells. Results show reduced FBP1 in PTC samples with a negative association with T stage. Functional assays indicate FBP1 acts as a hypoxia response inhibitor by modulating HIF-1α, suppressing tumorigenic and metastatic behaviors, suggesting the FBP1-HIF-1α axis as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/fbp1-over-expression-suppresses-hif-1-in-papillary-thyroid-cancer/338496/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/fbp1-over-expression-suppresses-hif-1-in-papillary-thyroid-cancer/338496.png","ImageObject",300,407,{"name":42,"@type":43},"Evangeline","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main purpose of this study in papillary thyroid cancer?","Question",{"text":63,"@type":64},"To determine whether FBP1 can serve as a predictive indicator and identify therapeutic targets by examining its regulation of HIF-1α and its effects on tumor behaviors.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does FBP1 relate to hypoxia response and HIF-1α in this research?",{"text":68,"@type":64},"The study proposes that FBP1 functions as a hypoxia response inhibitor by regulating HIF-1α expression in PTC cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental outcomes supported FBP1’s role in suppressing PTC progression?",{"text":72,"@type":64},"In vitro experiments showed that FBP1 overexpression inhibited proliferation, apoptosis-related changes, and invasion by modulating HIF-1α, while FBP1 expression was reduced in PTC tissues.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338496,1790245073,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nFBP1 over-expression suppresses HIF-1α in papillary thyroid cancer  \nHuashui Li2, Wenjun Xie2, Xiangqin Huang1 & Yifan Chen1􀀍  \nPapillary thyroid carcinoma (PTC) is generally a slow-growing disease with a favorable 10-year survival rate. However, about 10% of PTC cases show significant aggressiveness, with tendencies for local invasion or distant metastasis, the mechanisms of which remain unclear. This study aims to identify predictive indicators and explore new potential targets for clinical treatment, highlighting the need for novel biomarkers and therapeutic targets. We analyzed FBP1 expression in PTC tissues. Cell proliferation, apoptosis, and invasion were evaluated with and without FBP1 overexpression in PTC cells to assess FBP1’s effects. We then investigated whether FBP1 reduces PTC cell tumorigenesis and metastasis by regulating HIF-1α expression. FBP1 expression was reduced in PTC samples and showed a negative correlation with T stage. In vitro experiments indicated that FBP1 acts as a hypoxia response inhibitor, regulating tumor cells. Additionally, FBP1 inhibited the proliferation, apoptosis, and invasion of thyroid cancer cells by modulating HIF-1α expression. Our results provide new insights into the role of FBP1 in PTC progression and indicate that targeting the FBP1-HIF-1α axis could be a promising therapeutic approach for this disease.  \nKeywords Papillary thyroid tumor, FBP1, HIF-1α, Hypoxia  \nAdvances in ultrasonography (US) and US-guided fine-needle aspiration biopsy (FNAB) have contributed to arising incidence of thyroid carcinoma in recent decades. Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Although PTC is typically a slow-growing disease with a 10-year survival rate exceeding 90%1, studies indicate that about 10% of PTC patients show marked aggressiveness, increasing their risk of local invasion or distant metastasis2,3. Lymph node metastasis (LNM) occurs in more than 50% of PTC patients4–6 and is associated with higher recurrence rates and disease-specific mortality7,8. The mechanisms underlying the high aggressiveness observed in certain PTC cases remain unclear. Therefore, it is essential to investigate the molecular mechanisms to develop targeted therapies, as novel biomarkers and therapeutic targets are needed.  \nEnergy metabolism reprogramming, characterized by increased glycolysis even in the presence of oxygen, is now recognized as a key feature of cancer9, 10. Hypoxia-inducible factor-1α (HIF-1α), a critical protein involved in hypoxia response, plays a significant role in tumor cell survival and disease progression in various solid tumors, including thyroid cancer. Studies have shown a strong association between HIF-1α overexpression and higher tumor grades and metastasis in thyroid cancer11–13. Fructose-1,6-bisphosphatase 1 (FBP1), a tumor suppressor gene identified in multiple cancers, serves as the key rate-limiting enzyme in gluconeogenesis, which opposes glycolysis. FBP1 expression is often reduced in various cancers, and loss of FBP1 has been shown to accelerate tumor progression by promoting aerobic glycolysis, leading to poorer prognosis14–17. Li et al. reported that FBP1 inhibits cell glycolysis by blocking nuclear HIF function through direct interaction with the HIF inhibitory domain in renal cell carcinoma18. However, the mechanisms regulating FBP1 in PTC and the interaction between HIF-1α and FBP1 are not well understood. We hypothesized that FBP1 may act as a tumor suppressor in PTC by regulating HIF-1α expression. This study investigated FBP1’s role in regulating HIF-1α expression and the tumorigenic and metastatic behavior of PTC cells, with the aim of identifying predictive indicators for PTC progression and discovering new therapeutic targets.  \nMaterials and methods  \nData collection  \nGene expression profiles (raw counts) and clinical information were downloaded f","cbCaiaWnTCx6vddt","https://ap.wps.com/l/cbCaiaWnTCx6vddt","pdf",1599279,"English","# Materials and methods\n## Data collection\n## Patients and clinical samples\n## Protein extraction and Western blot analysis","[{\"question\":\"What was the main purpose of this study in papillary thyroid cancer?\",\"answer\":\"To determine whether FBP1 can serve as a predictive indicator and identify therapeutic targets by examining its regulation of HIF-1α and its effects on tumor behaviors.\"},{\"question\":\"How does FBP1 relate to hypoxia response and HIF-1α in this research?\",\"answer\":\"The study proposes that FBP1 functions as a hypoxia response inhibitor by regulating HIF-1α expression in PTC cells.\"},{\"question\":\"What experimental outcomes supported FBP1’s role in suppressing PTC progression?\",\"answer\":\"In vitro experiments showed that FBP1 overexpression inhibited proliferation, apoptosis-related changes, and invasion by modulating HIF-1α, while FBP1 expression was reduced in PTC tissues.\"}]","FBP1 over-expression suppresses HIF-1α in papillary thyroid cancer | PDF",1790023867,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/630e6404dc9885484b85d24becec9a04.webp",983,1291,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ed7da2e45c7b1470621453b7faff80f.webp",982,1290,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17446be8165cc181cea1fab78e07af8a.webp",981,1289,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/055596d21a6a6035a18efc66d228aefc.webp",980,1287]